These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20684041)

  • 1. Interaction of ibogaine with human alpha3beta4-nicotinic acetylcholine receptors in different conformational states.
    Arias HR; Rosenberg A; Targowska-Duda KM; Feuerbach D; Yuan XJ; Jozwiak K; Moaddel R; Wainer IW
    Int J Biochem Cell Biol; 2010 Sep; 42(9):1525-35. PubMed ID: 20684041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of bupropion with muscle-type nicotinic acetylcholine receptors in different conformational states.
    Arias HR; Gumilar F; Rosenberg A; Targowska-Duda KM; Feuerbach D; Jozwiak K; Moaddel R; Wainer IW; Bouzat C
    Biochemistry; 2009 Jun; 48(21):4506-18. PubMed ID: 19334677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of 18-methoxycoronaridine with nicotinic acetylcholine receptors in different conformational states.
    Arias HR; Rosenberg A; Feuerbach D; Targowska-Duda KM; Maciejewski R; Jozwiak K; Moaddel R; Glick SD; Wainer IW
    Biochim Biophys Acta; 2010 Jun; 1798(6):1153-63. PubMed ID: 20303928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship of ibogaine analogs interacting with nicotinic acetylcholine receptors in different conformational states.
    Arias HR; Feuerbach D; Targowska-Duda KM; Jozwiak K
    Int J Biochem Cell Biol; 2011 Sep; 43(9):1330-9. PubMed ID: 21642011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different interaction between tricyclic antidepressants and mecamylamine with the human alpha3beta4 nicotinic acetylcholine receptor ion channel.
    Arias HR; Targowska-Duda KM; Feuerbach D; Sullivan CJ; Maciejewski R; Jozwiak K
    Neurochem Int; 2010 Mar; 56(4):642-9. PubMed ID: 20117161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catharanthine alkaloids are noncompetitive antagonists of muscle-type nicotinic acetylcholine receptors.
    Arias HR; Feuerbach D; Targowska-Duda KM; Jozwiak K
    Neurochem Int; 2010 Sep; 57(2):153-61. PubMed ID: 20493225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (-)-Reboxetine inhibits muscle nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites.
    Arias HR; Ortells MO; Feuerbach D
    Neurochem Int; 2013 Nov; 63(5):423-31. PubMed ID: 23917086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tricyclic antidepressants and mecamylamine bind to different sites in the human alpha4beta2 nicotinic receptor ion channel.
    Arias HR; Rosenberg A; Targowska-Duda KM; Feuerbach D; Jozwiak K; Moaddel R; Wainer IW
    Int J Biochem Cell Biol; 2010 Jun; 42(6):1007-18. PubMed ID: 20223294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and functional interaction of (±)-2-(N-tert-butylamino)-3'-iodo-4'-azidopropiophenone, a photoreactive bupropion derivative, with nicotinic acetylcholine receptors.
    Arias HR; Feuerbach D; Targowska-Duda KM; Aggarwal S; Lapinsky DJ; Jozwiak K
    Neurochem Int; 2012 Dec; 61(8):1433-41. PubMed ID: 23103524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Doxylstearate-induced displacement of phencyclidine from its low-affinity binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Arch Biochem Biophys; 1999 Nov; 371(1):89-97. PubMed ID: 10525293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronaridine congeners inhibit human α3β4 nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites.
    Arias HR; Targowska-Duda KM; Feuerbach D; Jozwiak K
    Int J Biochem Cell Biol; 2015 Aug; 65():81-90. PubMed ID: 26022277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory mechanisms and binding site location for serotonin selective reuptake inhibitors on nicotinic acetylcholine receptors.
    Arias HR; Feuerbach D; Bhumireddy P; Ortells MO
    Int J Biochem Cell Biol; 2010 May; 42(5):712-24. PubMed ID: 20079457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity of coronaridine congeners at nicotinic acetylcholine receptors and inhibitory activity on mouse medial habenula.
    Arias HR; Jin X; Feuerbach D; Drenan RM
    Int J Biochem Cell Biol; 2017 Nov; 92():202-209. PubMed ID: 29042244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor.
    Arias HR
    Biochim Biophys Acta; 1998 Aug; 1376(2):173-220. PubMed ID: 9748559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms and binding site location for the noncompetitive antagonist crystal violet on nicotinic acetylcholine receptors.
    Arias HR; Bhumireddy P; Spitzmaul G; Trudell JR; Bouzat C
    Biochemistry; 2006 Feb; 45(7):2014-26. PubMed ID: 16475790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of phencyclidine potency on the nicotinic acetylcholine receptors from muscle and electric organ.
    Eterović VA; Lu R; Eakin AE; Rodríguez AD; Ferchmin PA
    Cell Mol Neurobiol; 1999 Dec; 19(6):745-57. PubMed ID: 10456235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors.
    Gerzanich V; Peng X; Wang F; Wells G; Anand R; Fletcher S; Lindstrom J
    Mol Pharmacol; 1995 Oct; 48(4):774-82. PubMed ID: 7476906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and structural interaction of (-)-reboxetine with the human α4β2 nicotinic acetylcholine receptor.
    Arias HR; Fedorov NB; Benson LC; Lippiello PM; Gatto GJ; Feuerbach D; Ortells MO
    J Pharmacol Exp Ther; 2013 Jan; 344(1):113-23. PubMed ID: 23010362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of selective serotonin reuptake inhibitors with neuronal nicotinic acetylcholine receptors.
    Arias HR; Feuerbach D; Targowska-Duda KM; Russell M; Jozwiak K
    Biochemistry; 2010 Jul; 49(27):5734-42. PubMed ID: 20527991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes.
    Arias HR; Feuerbach D; Targowska-Duda K; Kaczor AA; Poso A; Jozwiak K
    Biochim Biophys Acta; 2015 Feb; 1848(2):731-41. PubMed ID: 25475645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.